31
Jul
INFORMATION MANAGEMENT, CONFLICTS OF INTEREST
AND THE SAFETY OF SSRIs
Charles Medawar – Social Audit, August 2003
The Medicines Control Agency (MCA) ceased to exist on April 1st 2003, though little changed when it was reconstituted as the Medicines and Healthcare Products Regulatory Agency. In the MHRA the regulation of drugs and medical devices are now under the [...]
Posted in Drug Regulators and Conflicts of Interest, GSK, MHRA- Seroxat/Paxil, Paxil/Seroxat - Side Effects by: Princess
No Comments
31
Jul
COSTLY BENEFITS AND THE CONSPIRACY OF GOODWILL
Paper given by Charles Medawar at the annual meeting of the British Association for the Advancement of Science, Imperial College, London, 9 September 2000
“The operation was a great success; unfortunately the patient died.” This old joke about an obviously costly benefit also makes a serious point about the [...]
Posted in Do SSRI's work?, GSK, MHRA- Seroxat/Paxil by: Princess
No Comments
31
Jul
International Journal of Risk & Safety in Medicine 16 (2003/2004) 5–19 5
IOS Press
A comparison of adverse drug reaction
reports from professionals and users, relating
to risk of dependence and suicidal behaviour
with paroxetine
Charles Medawar a,∗ and Andrew Herxheimer b
a Social Audit Ltd., London, UK
bDIPEx Project, Department of Primary Health Care, University of Oxford, Oxford, UK
Abstract. We have previously [...]
Posted in GSK, MHRA- Seroxat/Paxil, Uncategorized by: Princess
No Comments
31
Jul
Paxil/Seroxat is an extremely dangerous drug! There are people that will sit there and say “but it helped me” and I would agree that it does benefit some but the reason the drug is dangerous is because GSK lied about it. We don’t know what to expect, we don’t know how to control the little [...]
Posted in GSK, MHRA- Seroxat/Paxil, Paxil Withdrawal, Paxil/Seroxat- Suicide, Paxil/Seroxat-Addiction, Paxil/seroxat withdrawal by: Princess
No Comments